Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis.
about
Immunosuppressive treatment for focal segmental glomerulosclerosis in adultsTreatment Strategies of Adult Primary Focal Segmental Glomerulosclerosis: A Systematic Review Focusing on the Last Two DecadesCalcineurin Inhibitors in the Treatment of Primary Focal Segmental Glomerulosclerosis: A Systematic Review and Meta-analysis of the LiteratureEarly change in proteinuria as a surrogate outcome in kidney disease progression: a systematic review of previous analyses and creation of a patient-level pooled dataset.A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis.Renal function and proteinuria after successful immunosuppressive therapies in patients with FSGS.Tacrolimus in the treatment of idiopathic nephrotic syndrome.Treatment of idiopathic FSGS with adrenocorticotropic hormone gel.Impact of the National Institutes of Health Focal Segmental Glomerulosclerosis (NIH FSGS) clinical trial on the treatment of steroid-resistant FSGS.Current and emerging treatments for idiopathic focal and segmental glomerulosclerosis in adults.Heavy-chain deposition disease: a morphological, immunofluorescence and ultrastructural assessment.Tacrolimus therapy in adult-onset steroid-resistant nephrotic syndrome due to a focal segmental glomerulosclerosis single-center experience.Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy.Cyclosporine-based immunosuppressive therapy for patients with steroid-resistant focal segmental glomerulosclerosis: a meta-analysis.
P2860
Q24242266-832559D9-D59D-41D5-966D-1E70099CD422Q26752836-4FC1F275-2DC6-4CD1-8AB4-44F5A6E30F4BQ30235177-94A6A118-1AB3-414C-9ABD-A54653434483Q35025425-5A9A0D60-278F-446E-86B3-67AA42D48190Q35669295-AED250EF-B937-494F-9C9F-78BEBD0D28BEQ36583388-C328F45C-1491-45B2-823A-CD137B828F6AQ36861628-2573BAE9-7EBF-40EA-A95B-289E40095865Q37359035-C4FD926B-177F-4BCF-BB0C-6324CE3D8030Q38068148-1CA9944F-73B5-41E3-BDF4-3816190B1951Q38085054-E5E9A54D-66D0-48F7-949E-1261A4DF6005Q38400768-0BA6BECB-21C1-467A-AAD6-8952F9152797Q44306449-1CCAA14E-94CA-4829-9DEE-D022312D28F3Q53625850-01530779-DE74-4D66-B91B-0D758583EDC6Q53742806-22550360-CA74-46FE-A1F6-596FA5AC4F47
P2860
Cyclosporine A and chlorambucil in the treatment of idiopathic focal segmental glomerulosclerosis.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Cyclosporine A and chlorambuci ...... segmental glomerulosclerosis.
@en
type
label
Cyclosporine A and chlorambuci ...... segmental glomerulosclerosis.
@en
prefLabel
Cyclosporine A and chlorambuci ...... segmental glomerulosclerosis.
@en
P2093
P1476
Cyclosporine A and chlorambuci ...... segmental glomerulosclerosis.
@en
P2093
Bernd Grabensee
Bernhard K Krämer
Frieder Keller
German Collaborative Glomerulonephritis Study Group
Ingeborg Zäuner
Katrin Ivens
Norbert Braun
Peter Heering
Peter Schollmeyer
Reinhard Fünfstück
P356
10.1053/J.AJKD.2003.09.027
P577
2004-01-01T00:00:00Z